Biomerica First Quarter 2025 Earnings: US$0.078 loss per share (vs US$0.067 loss in 1Q 2024)

Biomerica (NASDAQ:BMRA) First Quarter 2025 Results

Key Financial Results

• Revenue: US$1.81m (up 5.5% from 1Q 2024).
• Net loss: US$1.32m (loss widened by 16% from 1Q 2024).
• US$0.078 loss per share (further deteriorated from US$0.067 loss in 1Q 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Biomerica shares are up 13% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Biomerica has 4 warning signs (and 3 which are a bit concerning) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.